NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung CancerBusiness Wire • 05/22/25
NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platformPRNewsWire • 04/29/25
NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 04/22/25
NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual MeetingBusiness Wire • 04/22/25
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of PathlineBusiness Wire • 03/10/25
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025Business Wire • 01/29/25
NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term GuidanceInvestors Business Daily • 01/15/25
NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial PlanBusiness Wire • 01/15/25
NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?Zacks Investment Research • 01/15/25
NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/06/25